Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Implanet S.A. (ALIMP.PA)
EUR0.18
0.00 (-0.56%)
FR PAR Healthcare Medical - Devices
Address
Technopole Bordeaux Montesquieu 33650
Martillac, FR
Martillac, FR
CEO
Ludovic Lastennet
Website
implanet.com
IPO
2013-11-25
ISIN FR0013470168
Also trades on
Euronext Paris · ALIMP.PA (EUR)
Other OTC · IMPZY (USD)
Description
Implanet S.A., together with its associated companies, is dedicated to the research, development, manufacturing, and commercialization of spinal and orthopedic medical implants. The firm's product portfolio addresses both spinal and knee needs. Its spinal offerings encompass various posterior fixation systems, including the Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Jazz Frame, and ISS-Jazz Screw lines. Furthermore, Implanet S.A. provides knee prostheses, which are marketed under the Madison brand. The company has a significant strategic alliance with Shanghai Sanyou Medical Co, Ltd. Established in 2006, Implanet S.A. operates from its headquarters in Martillac, France.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
EUR0.18
0.00 (-0.56%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
87.1K
Beta
0.62
Float Shares
100.14M
Free Float %
69.6%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.22% | -2.33% | -6.01% | -12.10% | -4.60% | -7.00% | +89.92% | +6.71% | -80.00% | -99.72% | -99.94% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.18
Ratings Trend (MoM)
0% Bullish
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-0.35
Distress
Piotroski F-Score
5 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
D+
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%+32.6% ★ Q4'25: +109.7% (vs Q4'23)
-
EPS growth Medical - Devices: +28.5%+18.5% Q4'25: +87.5% (vs Q4'23)
-
FCF margin FCF growth · Medical - Devices: +30.9%-51.6% Q4'25: -17.8% (vs Q4'23)
-
EBIT margin Medical - Devices: +6.2%-33.8% Q4'25: -50.4% (vs Q4'23)
-
ROIC Medical - Devices: +3.3%-127.0% Q4'25: -404.7% (vs Q4'23)
-
Share dilution Medical - Devices: 0.0%+23.1% Q4'25: +303.4% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×-1.41× Q4'25: -0.44× (vs Q4'23)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
6.65M
est: 6.70M (-0.7%)
|
7.83M
est: 7.83M (+0.0%)
|
7.84M
est: 7.84M (+0.0%)
|
6.72M
est: 6.70M (+0.3%)
|
7.41M
est: 7.41M (+0.0%)
|
3.89M
est: 6.01M (-35.3%)
|
6.14M
est: 7.74M (-20.6%)
|
8.03M
est: 8.03M (0.0%)
|
7.45M
est: 9.70M (-23.2%)
|
9.41M
est: 11.60M (-18.9%)
|
| EBITDA |
-6.36M
est: -3.08M (-106.2%)
|
-5.82M
est: -3.60M (-61.7%)
|
-5.15M
est: -3.61M (-42.8%)
|
-4.43M
est: -3.08M (-43.7%)
|
-2.16M
est: -3.41M (+36.7%)
|
-1.46M
est: -2.77M (+47.2%)
|
-3.26M
est: -3.56M (+8.4%)
|
-2.47M
est: -3.70M (+33.3%)
|
-5.08M
est: -4.46M (-13.7%)
|
-3.82M
est: -5.25M (+27.3%)
|
| EBIT |
-7.34M
est: -4.04M (-81.6%)
|
-6.64M
est: -4.72M (-40.6%)
|
-6.07M
est: -4.73M (-28.3%)
|
-4.91M
est: -4.04M (-21.5%)
|
-2.86M
est: -4.47M (+36.1%)
|
-2.42M
est: -3.63M (+33.2%)
|
-3.86M
est: -4.67M (+17.3%)
|
-3.08M
est: -4.84M (+36.4%)
|
-6.41M
est: -5.85M (-9.5%)
|
-4.93M
est: -6.34M (+22.2%)
|
| Net Income |
-8.01M
est: -2.87B (+99.7%)
|
-7.29M
est: -1.54B (+99.5%)
|
-6.61M
est: -1.38B (+99.5%)
|
-5.55M
est: -553.29M (+99.0%)
|
-3.65M
est: -368.86M (+99.0%)
|
-3.98M
est: -81.84M (+95.1%)
|
-4.61M
est: 1.15M (-499.9%)
|
-3.54M
est: -2.31M (-53.6%)
|
-6.68M
est: -1.15M (-479.2%)
|
-4.37M
est: -1.42M (-207.6%)
|
| SGA |
8.39M
est: 5.93M (+41.5%)
|
9.03M
est: 6.92M (+30.4%)
|
8.06M
est: 6.93M (+16.2%)
|
7.47M
est: 5.93M (+26.0%)
|
6.63M
est: 6.55M (+1.2%)
|
4.35M
est: 5.32M (-18.1%)
|
6.49M
est: 6.84M (-5.2%)
|
7.72M
est: 7.10M (+8.8%)
|
2.84M
est: 8.58M (-66.9%)
|
8.49M
est: 9.73M (-12.7%)
|
| EPS |
-33.20
est: -24.62 (-34.8%)
|
-15.72
est: -13.24 (-18.8%)
|
-11.37
est: -11.85 (+4.1%)
|
-7.43
est: -4.74 (-56.7%)
|
-3.07
est: -3.16 (+2.9%)
|
-1.27
est: -0.70 (-81.1%)
|
-0.54
est: 0.01 (-5,566.7%)
|
-0.17
est: -0.02 (-760.5%)
|
-0.17
est: -0.01 (-1,621.0%)
|
-0.04
est: -0.01 (-278.6%)
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-26 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-25 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-4.67M
OE per share TTM
-0.06
Owner's Yield
-15.28%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
16.9%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
-91.7K
Shares Outstanding
143.82M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ludovic Lastennet | Chief Executive Officer, Commercial Director & Director | 294.0K | male |
| Benjamin Letienne | Vice President of Marketing & International Sales and Director | — | male |
| David Dieumegard | Vice President of Financial | — | male |
| Yvanna Peigne | Operations Manager | — | female |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ALIMP.PA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
